Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2016-06-07 Report Publication Anno…
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Posting of Annual Report & Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is a short announcement (4209 characters) released via RNS (RNS Number : 3760A) on June 7, 2016. The title explicitly states: 'Posting of Annual Report & Notice of AGM'. The body confirms that the 'Annual Report and Accounts for the year ended 31 December 2015, Notice of the Annual General Meeting ("AGM") and a Form of Proxy have been posted to shareholders and are now available on the Company's website'. According to Rule 2 ('MENU VS MEAL' Rule), when a document announces that a report (like an Annual Report) has been published or posted elsewhere, it should be classified as a Report Publication Announcement (RPA), not the report itself (10-K or AGM-R).
2016-06-07 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document begins with an 'RNS Number' and is dated May 26, 2016. The content explicitly announces a 'Director/PDMR Shareholding' transaction where a Non-Executive Director purchased shares and the CFO was granted share options. This type of insider transaction reporting is a specific regulatory disclosure. While it relates to director dealings (DIRS), the format, use of the RNS number, and the general nature of the announcement strongly suggest it is a standard regulatory filing disseminated via the London Stock Exchange's RNS service. Since 'Director's Dealing' (DIRS) is a specific category for personal share transactions by directors, this is the most precise fit over the general 'Regulatory Filings' (RNS) fallback, even though it is distributed via RNS.
2016-05-26 English
Final Results
Earnings Release Classification · 99% confidence The document is an RNS announcement dated May 24, 2016, titled 'Final results' for the year ended 31 December 2015. It contains key financial highlights (Revenue, Operating loss, Loss per share) and operational highlights, followed by Chairman's and CEO's reports detailing the full year's performance. This structure—announcing preliminary/final results with key figures and management commentary for a full fiscal year—is characteristic of an Earnings Release (ER) or, given the depth and inclusion of Chairman/CEO reports, often aligns with the content found in a full Annual Report (10-K) or an Interim Report (IR). However, since it explicitly states 'preliminary results for the year ended 31 December 2015' and is disseminated via RNS, it functions as the initial, comprehensive announcement of annual performance before a formal 10-K filing might occur. The content is too detailed for a simple Earnings Release (ER) which usually contains only key highlights. It is not a 10-K as it is an RNS announcement of preliminary results. It is also not an Interim Report (IR) as it covers the full year. The closest fit for a comprehensive annual performance summary released via regulatory channels, especially when labeled 'preliminary results' preceding a potential full filing, is often classified as an Earnings Release (ER) if it's the first formal disclosure, or sometimes an Annual Report (AR) if it contains the audit opinion, which is not explicitly stated here. Given the structure of key highlights followed by detailed management discussion covering the full year, and its dissemination as an RNS, it most closely matches the function of an Earnings Release (ER) or a comprehensive Annual Report disclosure. Since it explicitly states 'preliminary results' and is an RNS, ER is the most appropriate code for the initial release of annual figures, even if it is quite detailed. FY 2015
2016-05-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7638U' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', specifically reporting an acquisition or disposal of voting rights by Livingbridge VC LLP concerning Eden Research plc. This type of mandatory disclosure regarding changes in significant shareholdings (crossing thresholds) aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although RNS is mentioned, the specific content is a major holding change, making MRQ the most precise classification over the general RNS fallback.
2016-04-11 English
Placing to raise £2.6m
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated March 30, 2016. The content explicitly announces a 'Placing to raise £2.6m' through the issuance of new ordinary shares to institutional shareholders. This action directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it is distributed via RNS, the core subject matter is financing, which is more specific than the general regulatory fallback (RNS).
2016-03-30 English
Approval of 3AEY in Spain
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 6498P' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange END'. This strongly indicates that the document is a regulatory announcement disseminated through the London Stock Exchange's Regulatory News Service (RNS). The content details a specific business update (product authorization in Spain) rather than being a comprehensive annual report (10-K), an earnings release (ER), or a formal presentation (IP). Since it is a general regulatory announcement that doesn't fit the more specific categories like DIV, DIRS, or MANG, the most appropriate classification is the general regulatory filing category.
2016-02-22 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.